You are a Senior Medical Oncologist and have been approached by your Government to be a part of the panel who will be reviewing a new screening test for Breast Cancer. The screening test is 99% sensitive and 98% specific. It is not invasive and is associated with very few adverse outcomes. It costs $250,000 / patient to administer. Which factor makes this screening test not a very good screening test.